Search research articles
Contact Us
Filters
Showing results (111-120 of 232) with videos related to
Page
of 24
Sort By:
Pediatric Blood & Cancer
|
July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study
Orren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors
Ramesh K Ramanathan, Merrill J Egorin, Charles Erlichman, et al.
Investigational New Drugs
|
September 24, 2009
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors
Charles J Nock, Joanna M Brell, Joseph A Bokar, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2020
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
Anand Joshi, Jianxia Guo, Julianne L Holleran, et al.
Neuro-Oncology
|
August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study
Kristin A Bradley, Ian F Pollack, Joel M Reid, et al.
JCO Precision Oncology
|
February 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors
Yiduo Hu, Azeet Narayan, Yunshan Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2013
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer
Joyce F Liu, Sara M Tolaney, Michael Birrer, et al.
Cancer Chemotherapy and Pharmacology
|
August 2, 2008
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
Joanna M Brell, Smitha S Krishnamurthi, Milind Javle, et al.
Cancer Chemotherapy and Pharmacology
|
December 17, 2008
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors
William R Schelman, Sherry Morgan-Meadows, Rebecca Marnocha, et al.
Cancer Chemotherapy and Pharmacology
|
November 13, 2004
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck
Matthew M Cooney, Kou-Yi Tserng, Vinit Makar, et al.
Page
of 24
Search research articles
Search
Showing results (111-120 of 232) with videos related to
Sort By:
Page
of 24
Pediatric Blood & Cancer
|
July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study
Orren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors
Ramesh K Ramanathan, Merrill J Egorin, Charles Erlichman, et al.
Investigational New Drugs
|
September 24, 2009
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors
Charles J Nock, Joanna M Brell, Joseph A Bokar, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2020
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
Anand Joshi, Jianxia Guo, Julianne L Holleran, et al.
Neuro-Oncology
|
August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study
Kristin A Bradley, Ian F Pollack, Joel M Reid, et al.
JCO Precision Oncology
|
February 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors
Yiduo Hu, Azeet Narayan, Yunshan Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2013
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer
Joyce F Liu, Sara M Tolaney, Michael Birrer, et al.
Cancer Chemotherapy and Pharmacology
|
August 2, 2008
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
Joanna M Brell, Smitha S Krishnamurthi, Milind Javle, et al.
Cancer Chemotherapy and Pharmacology
|
December 17, 2008
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors
William R Schelman, Sherry Morgan-Meadows, Rebecca Marnocha, et al.
Cancer Chemotherapy and Pharmacology
|
November 13, 2004
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck
Matthew M Cooney, Kou-Yi Tserng, Vinit Makar, et al.
Page
of 24